SCHEMBL27465846

SCHEMBL27465846

Clc1ccnc2ccc(SC3CCC3)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.39
MAOA P21397 4/20 0.38
MAOB P27338 4/20 0.38
KMT5B Q4FZB7 2/20 0.37
KMT5C Q86Y97 2/20 0.37
AR P10275 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
NR4A2 P43354 1/20 0.34
MGLL Q99685 1/20 0.34
AXL P30530 1/20 0.33
PRKCI P41743 1/20 0.33
PTGIR P43119 1/20 0.32
KCNH2 Q12809 1/20 0.32
ATM Q13315 1/20 0.32
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30979488 1.00 MET (0.39) METMAOAMAOBKMT5BKMT5C
SCHEMBL27461348 0.94 MET (0.40) METMAOAMAOBKMT5BKMT5C
SCHEMBL599987 0.87 MET (0.37) METMAOAMAOBKMT5BKMT5C
SCHEMBL30979525 0.74 SMN1; SMN2 (0.44) METDYRK1BSMN1; SMN2NR4A2AXL
SCHEMBL4015831 0.74 SMN1; SMN2 (0.44) METDYRK1BSMN1; SMN2NR4A2AXL
SCHEMBL17552281 0.74 SMN1; SMN2 (0.44) METDYRK1BSMN1; SMN2NR4A2MGLL
SCHEMBL14717415 0.71 SMN1; SMN2 (0.41) METARDYRK1BSMN1; SMN2NR4A2
SCHEMBL599549 0.71 SMN1; SMN2 (0.51) METARDYRK1BSMN1; SMN2NR4A2
SCHEMBL10119033 0.69 MET (0.39) METDYRK1BSMN1; SMN2NR4A2AXL
SCHEMBL27465843 0.69 MET (0.39) METDYRK1BSMN1; SMN2NR4A2AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112854-A1 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2024-05-30 WO disclosed